Babak Sarani, MD, FACS, FCCM, explains what the designation of a Level I Trauma Center means to patients in need of emergency care. He discusses the staffing, equipment and procedures that go into providing care for the most critically injured patients. Listen Now | GW Hospital HealthCast , a...
Nancy D. Gaba, MD, FACOG, and Whitney Pinger, CNM, FACNM, discuss the importance of preparing for childbirth with a solid birth plan in place. Dr. Gaba and Whitney advise expectant mothers to seek information and guidance from friends and medical professionals to tailor a plan that best fits their...
Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at GW Cancer Center, accepted a check from the Avon Foundation at the annual Avon Walk in Washington, D.C. The money will fund a patient navigator who will provide resources to help breast cancer patients in the D.C. area.
A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.
Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.
Cancer patients dealing with the often painful and unrecognized impacts of chemotherapy and other treatment on the skin, hair and nails have a new place at George Washington University to turn to for help.
When chronic, unresponsive eruptions don't respond to standard treatments, think cutaneous T-cell lymphoma, says L. Frank Glass, MD in an interview with Adam Friedman, MD.
WASHINGTON (June 15, 2017) — The George Washington University (GW) Cancer Center is pleased to announce the opening of the Supportive Oncodermatology Clinic . This clinic is the only one of its kind in the Washington, D.C. region, and one of only a handful of such clinics in the country. The clinic...
WASHINGTON (June 14, 2017) — Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment. Research published in Nature Communications by...
Congratulations to Jennifer Bires, LICSW, OSW-C, program coordinator of patient support services at the George Washington University (GW) Cancer Center. Bires will be named 2017 Oncology Social Worker of the Year at the Association of Oncology Social Work (AOSW) Annual Conference to be held May 31-June 2 in Denver.
Congratulations to Aubrey Van Kirk Villalobos, M.P.H., M.Ed., director of cancer control and health equity at the Institute for Patient-Centered Initiatives and Health Equity at the George Washington University (GW) Cancer Center, who was part of the winning Urgent Wellness team from the GW New...
Dr. Kaltman spent time at Equinox Bethesda discussing the upcoming Force Fitness Fest and hereditary cancer prevention with Great Day Washington. Check out the videos from the interview here
Adam Friedman, M.D., Associate Professor of Dermatology at the GW School of Medicine and Health Sciences, wrote an article for the Huffington Post on avoiding ultraviolet radiation. Shedding Some Light: Avoiding Sunshine Can Kill You?
Dr. Edward M. Sotomayor was a featured speaker on the Politico Pro Health Care series where the topic was drug safety. The panel discussed the future of the FDA in the new administration, drug effictiveness and more. Watch the full video here
Allison Harvey, MPH, CHES, of George Washington University, evaluates preliminary outcomes among primary care and oncology providers who took part in the Cancer Survivorship E-Learning Series (Abstract 78). Watch the Full Interview
Eduardo M. Sotomayor, M.D. , director of the George Washington (GW) University Cancer Center and professor of medicine at the GW School of Medicine and Health Sciences, will speak at the Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options hosted by the D.C. Lymphoma...
The George Washington University (GW) Cancer Center is pleased to announce that Mitchell R. Smith, M.D., Ph.D., has been appointed as the associate center director for clinical investigations.
Ahead of World Cancer Day, prominent Young Leaders from the Union for International Cancer Control (UICC) presented their vision for a new generation of cancer control access and equity in a commentary published in the latest Lancet Oncology journal.
The GW Cancer Center is pleased to announce that Frank Glass, M.D., an internationally renowned dermatologist and dermatopathologist who specializes in skin malignancies and in the diagnosis and treatment of Cutaneous T-cell Lymphoma (CTCL), has joined the GW Cancer Center in fall 2016.
Published in the Journal of the European Academy of Dermatology & Venereology, the study had nearly 20,000 participants from 23 countries
Patricia Berg, Ph.D., professor of biochemistry and molecular medicine at the GW School of Medicine and Health Sciences, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.
Years of hard work and dedication toward enhancing George Washington University's cancer research and care culminated at the grand opening of the GW Cancer Center’s new space in the Science and Engineering Hall.
The George Washington University (GW) formally launched the GW Cancer Center with a ribbon-cutting and grand opening celebration the evening of Wednesday, Dec. 7. The celebration took place on the eighth floor of the Science and Engineering Hall, where the new GW Cancer Center offices and lab spaces are located. The event signals a historic commitment from GW in the fight against cancer and the commitment to finding a cure.
The George Washington University (GW) is pleased to formally launch the GW Cancer Center with a ribbon cutting ceremony and grand opening celebration. The event will be held at the GW Cancer Center’s new lab and office space located on the eighth floor of the GW Science and Engineering Hall on Wed., Dec. 7 at 5:30 p.m.
George Washington University (GW) researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection.